We try to translate our intellectual and practical know-how into improving the health and well-being of our society.
LifeTag, founded on January 29th 2016, is a Portuguese technology-based startup that is focused on Research & Development of non-invasive technologies for evaluating metabolism and improving the diagnosis of chronic metabolic diseases. Our main targets include Type-2 diabetes and non-alcoholic fatty liver disease – diseases that are predicted to soon reach epidemic proportions in many parts of the world.
LifeTag is dedicated to developing cutting-edge methodologies for enhancing our understanding of metabolic diseases thereby providing better knowledge for improving human health. To this end, Lifetag, supported by strong foundations of respect to the other, is currently focused on the following:
Research and development of new processes, technologies or knowledge that inform important nutritional and metabolic processes related to obesity, diabetes, fatty liver disease and many others.
Developing novel clinical tests for improved diagnosis and staging of metabolic diseases.
It is our mission to translate our intellectual and practical know-how into improving the health and well-being of our society.